Tibolone
(Synonyms: 替勃龙) 目录号 : GC41153Tibolone是一种合成类固醇，具有弱雌激素、孕激素及雄激素活性。
Cas No.:5630-53-5
Sample solution is provided at 25 µL, 10mM.
_1-3.$$$39978408@51.jpg');)
_1-9.$$$38538795@65.jpg');)
_1-9.$$$39112701@51.jpg');)
_1-7.$$$37316672@70.jpg');)
_366-372.$$$36198801@70.jpg');)
.$$$38565142@65.jpg');)
_1867-1883.$$$33248023@67.jpg');)
_eads6055.$$$39977546@45.jpg');)
_eadm9805.$$$40080571@45.jpg');)
_eadj3020.$$$39666821@45.jpg');)
_1-20.$$$39757301@28.jpg');)
_1-24.$$$38898113@28.jpg');)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
_1-19.$$$37460805@44.jpg');)
_1291-1307.$$$34518654@46.jpg');)
Tibolone is a synthetic steroid that possesses weak estrogenic, progestational and androgenic properties [1]. The selective local metabolism of Tibolone into the Δ4 metabolite, which has progestogenic properties, prevents endometrial proliferation and negates the requirement for the addition of a progestogen [2]. Tibolone has been widely used in various animal models to alleviate vascular dilation and constriction and to improve the functions of the urinary and reproductive systems[3].
In vitro, Tibolone treatment for 48 hours significantly inhibited the proliferation of MCF-7 cells, with an IC50 value of 0.019μM[4]. Treatment of cells with 10nM Tibolone for 24 hours significantly reduced glucose deprivation-induced cell death in T98G cells and maintained cell morphology, while reducing nuclear fragmentation[5]. Treatment with 10nM Tibolone for 24 hours can reduce the cytotoxicity of 2mM palmitic acid on normal human astrocytes (NHAs) and decrease the loss of cardiolipin[6].
In vivo, Tibolone treatment via oral administration at a dose of 0.04mg/kg/day for 15 days significantly reduced the mean arterial pressure of renal vascular hypertension rats after ovary removal (OVX), albeit lowering total cholesterol and high-density lipoprotein (HDL) cholesterol levels[7]. Oral administration of 1mg/day of Tibolone for three consecutive months can enhance the bone integration process of intramedullary titanium implants in OVX rats, preventing the decline in bone mineral density (BMD) and weight gain after OVX [8].
References:
[1] Albertazzi P, Di Micco R, Zanardi E. Tibolone: a review[J]. Maturitas, 1998, 30(3): 295-305.
[2] Kenemans P, Speroff L, International Tibolone Consensus Group. Tibolone: clinical recommendations and practical guidelines: a report of the International Tibolone Consensus Group[J]. Maturitas, 2005, 51(1): 21-28.
[3] Del Río J P, Molina S, Hidalgo-Lanussa O, et al. Tibolone as hormonal therapy and neuroprotective agent[J]. Trends in Endocrinology & Metabolism, 2020, 31(10): 742-759.
[4] Sookvanichsilp N, Boonleang C, Sookvanichsilp N. Alendronate, raloxifene and tibolone inhibit the proliferation-stimulating activity of 17 (beta)-estradiol in MCF-7 cells[J]. 2005.
[5] Rodriguez M Á, Garcia-Segura L M, Cabezas R, et al. Tibolone protects T98G cells from glucose deprivation[J]. The Journal of steroid biochemistry and molecular biology, 2014, 144: 294-303.
[6] Martin-Jiménez C, González J, Vesga D, et al. Tibolone ameliorates the lipotoxic effect of palmitic acid in normal human astrocytes[J]. Neurotoxicity research, 2020, 38(3): 585-595.
[7] Gilglioni E H, Campos L B, Oliveira M C, et al. Beneficial effects of tibolone on blood pressure and liver redox status in ovariectomized rats with renovascular hypertension[J]. Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences, 2013, 68(5): 510-520.
[8] Apostu D, Lucaciu O, Mester A, et al. Tibolone, alendronate, and simvastatin enhance implant osseointegration in a preclinical in vivo model[J]. Clinical oral implants research, 2020, 31(7): 655-668.
Tibolone是一种合成类固醇，具有弱雌激素、孕激素及雄激素活性[1]。Tibolone在局部的特异性代谢过程会转化为具有孕激素作用的Δ4代谢产物，这一过程能够抑制子宫内膜的增生，并且无需再额外添加孕激素[2]。Tibolone已广泛应用于多种动物模型中，用于改善血管舒缩功能及泌尿生殖系统功能[3]。
在体外，Tibolone处理48小时可显著抑制MCF-7细胞增殖，IC50值为0.019μM[4]。使用10nM的Tibolone处理T98G细胞24小时，能显著减轻葡萄糖剥夺诱导的细胞死亡，维持细胞形态并减少核碎裂[5]。以10nM的Tibolone处理正常人星形胶质细胞(NHAs)24小时，可减轻棕榈酸诱导的细胞毒性，减少心磷脂损失[6]。
在体内，卵巢切除（OVX）的肾血管性高血压大鼠每日口服0.04mg/kg/day剂量的Tibolone，连续15天，可显著降低平均动脉压，且总胆固醇和高密度脂蛋白胆固醇水平也有所下降[7]。连续三个月每日口服1mg/day剂量的Tibolone，能增强OVX大鼠髓内钛植入体的骨整合过程，防止OVX后骨密度下降及体重增加[8]。
| Cell experiment [1]: | |
Cell lines | T98G cells |
Preparation Method | T98G cells were inoculated into a multi-well plate, and the culture medium was DMEM supplemented with fetal bovine serum (FBS). The cells were cultured for 24 hours. Before treating the cells with Tibolone, a 24-hour serum starvation treatment was performed using DMEM medium without L-glutamine, serum, and phenol red. A 40mM Tibolone stock solution was prepared, with 100% DMSO as the solvent. Then, the Tibolone was diluted in the DMEM medium without L-glutamine, serum, and phenol red. The cells were treated with different concentrations of Tibolone (0, 10, 20, 50, and 70μM) for 24 hours before being treated with palmitic acid. 0.2% DMSO was used as the control for Tibolone. After the Tibolone pretreatment was completed, the culture medium was replaced with 1mM palmitic acid or the control (2.5% BSA and 2mM carnitine), and the cells were cultured for 24 hours. Then, cell viability was detected. |
Reaction Conditions | 0, 10, 20, 50, and 70μM; 24h |
Applications | Tibolone significantly can restore the viability of T98G cells treated with palmitic acid. |
| Animal experiment [2]: | |
Animal models | Female albino Wistar rats |
Preparation Method | Eighty female Wistar albino rats, aged 9-11 weeks and weighing 200±50g, were raised in a standard sterile environment and had not undergone any genetic modification. The rats were housed in an environment with a temperature of 21°C and a 12-hour light/12-hour dark cycle. Standard pellet feed and water were provided, and the rats were allowed to freely consume. The rats were randomly divided into five groups: Group I (control group + ovariectomy), Group II (control group + sham ovariectomy), Group III (alendronate + ovariectomy), Group IV (simvastatin + ovariectomy), and Group V (Tibolone + ovariectomy). Group I and II received no drug treatment and were only provided with free access to food and water. Three months after ovariectomy and sham ovariectomy, bilateral femoral intramedullary nail fixation surgeries were performed on all groups of rats, followed by drug treatment. Three months after the intramedullary nail implantation, bilateral femurs were collected for histological examination. The treatment groups were orally administered medication starting from the first day after surgery and continued for 12 weeks. Group III was given alendronate twice a week at a dose of 3mg/kg; Group IV was given simvastatin daily at a dose of 5mg/kg; Group V was given Tibolone daily at a dose of 1mg/day. |
Dosage form | 1mg/day for 3 months; p.o. |
Applications | Tibolone treatment enhanced the bone integration process of intramedullary titanium implants in OVX rats. |
References: | |
| Cas No. | 5630-53-5 | SDF | |
| 别名 | 替勃龙 | ||
| Canonical SMILES | O[C@@]1(C#C)CC[C@@]2([H])[C@]([C@]3([H])CC[C@@]21C)([H])[C@H](C)CC4=C3CCC(C4)=O | ||
| 分子式 | C21H28O2 | 分子量 | 312.5 |
| 溶解度 | DMF: 30 mg/ml,DMF:PBS (pH 7.2)(1:3): .25 mg/ml,DMSO: 20 mg/ml,Ethanol: 2 mg/ml | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 3.2 mL | 16 mL | 32 mL |
| 5 mM | 640 μL | 3.2 mL | 6.4 mL |
| 10 mM | 320 μL | 1.6 mL | 3.2 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet